A Study to Evaluate MK-0482 for Relapsed/Refractory Acute Myeloid Leukemia
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and recommended Phase 2 dose (RP2D) of MK-0482. There are 2 parts of this study. Part 1 is